Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection

Freenome common stock expected to begin trading on the Nasdaq Capital Market under the ticker symbol 'FRNM' on July 21, 2026 –– Gross proceeds ...